Do new cancer drugs offer good value for money? The perspectives of oncologists, health care policy makers, patients, and the general population

Overview of attention for article published in Patient preference and adherence, December 2015

Altmetric Badge

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 25 Dimensions

Readers on

mendeley: 59 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 25 publications that cite this research output.

25

The most recent citing publications are shown below. View all 25 publications that cite this research output on Dimensions.

Patient preferences do matter: a discrete choice experiment conducted with breast cancer patients in six European countries, with latent class analysis

Article in International Journal of Technology Assessment in Health Care (April 2023)

Impact of cetuximab plus cisplatin alone and cetuximab plus cisplatin and paclitaxel regimen on humanistic outcome in head and neck cancer

Article in Journal of the Egyptian National Cancer Institute (January 2023)

Considerations for the Utility of Real-World Evidence Beyond Trial Data in Advanced NSCLC: The Case of Frontline Tyrosine Kinase Inhibitors

Article in Cancer Management and Research (December 2022)